Zevenbergen Capital Investments’s Mead Johnson Nutrition Company MJN Stock Holding History

Zevenbergen Capital Investments’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,925	Closed	-$561K	–	87
2016 Q4	$561K	Sell	7,925 -1,275	-14%	-$95K	0.03%	64
2016 Q3	$727K	Buy	9,200 +2,370	+35%	+$202K	0.03%	62
2016 Q2	$620K	Buy	6,830 +1,210	+22%	+$102K	0.03%	58
2016 Q1	$478K	Buy	5,620 +1,450	+35%	+$108K	0.02%	61
2015 Q4	$329K	Buy	4,170 +670	+19%	+$52.8K	0.01%	69
2015 Q3	$246K	Sell	3,500 -250	-7%	-$20.6K	0.01%	68
2015 Q2	$338K	Hold	3,750	–	–	0.01%	61
2015 Q1	$377K	Buy	3,750 +200	+6%	+$20.2K	0.02%	58
2014 Q4	$357K	Buy	3,550 +400	+13%	+$39.9K	0.02%	65
2014 Q3	$303K	Buy	3,150 +55	+2%	+$5.21K	0.01%	65
2014 Q2	$288K	Buy	+3,095	New	+$271K	0.01%	65
2013 Q3	–	Sell	-2,700	Closed	-$214K	–	68
2013 Q2	$214K	Buy	+2,700	New	+$216K	0.01%	57

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Zevenbergen Capital Investments's MJN Position: Q1 2017 in Review

Zevenbergen Capital Investments sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 7,925 shares — an estimated $561K sold.

Zevenbergen Capital Investments first reported a position in MJN in Q2 2013 and held it in 12 quarters. The position peaked at $727K in Q3 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Zevenbergen Capital Investments reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Zevenbergen Capital Investments sold 7,925 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $561K.
Zevenbergen Capital Investments first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 12 quarters.
Zevenbergen Capital Investments's Mead Johnson Nutrition Company position peaked at $727K in Q3 2016.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Zevenbergen Capital Investments's 13F filing for Q1 2017, filed 12 May 2017.